When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'

David E Gyorki, Andrew Barbour, Mark Hanikeri, Victoria Mar, Shahneen Sandhu, John F. Thompson

Research output: Contribution to journalArticleOtherpeer-review

6 Citations (Scopus)

Abstract

A sentinel lymph node biopsy is a surgical staging procedure performed for patients with primary cutaneous melanoma who are clinically lymph-node negative to determine whether there is low volume nodal metastasis in the draining lymph node field. A systematic review was recently performed to update the Australian clinical practice guidelines for the diagnosis and management of melanoma, addressing the question, 'When is a sentinel lymph node biopsy indicated?' This article discusses the findings of the systematic review and the evidence base for the updated guidelines.

Original languageEnglish
Pages (from-to)274-277
Number of pages4
JournalAustralasian Journal of Dermatology
Volume58
Issue number4
DOIs
Publication statusPublished - Nov 2017

Keywords

  • Guidelines
  • Melanoma
  • Sentinel node biopsy

Cite this